<DOC>
	<DOCNO>NCT00163423</DOCNO>
	<brief_summary>The aim study compare efficacy ciclesonide versus fluticasone propionate lung function , time first asthma exacerbation , asthma symptom , use rescue medication , quality life patient mild moderate asthma . Ciclesonide inhale one dose level daily ; fluticasone propionate inhale one dose level twice daily . The study duration consist baseline period ( 2 4 week ) treatment period ( 24 week ) . The study provide data safety tolerability ciclesonide .</brief_summary>
	<brief_title>Efficacy Ciclesonide Versus Fluticasone Propionate Patients With Mild Moderate Asthma ( 12 75 ) ( BY9010/M1-142 )</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Ciclesonide</mesh_term>
	<mesh_term>Fluticasone</mesh_term>
	<criteria>Main Outpatients Written inform consent History bronchial asthma least 6 month Good health exception asthma Treated inhale steroid maximum daily constant dosage 250 mcg fluticasone propionate equivalent FEV1 80 105 % predict Main Concomitant severe disease disease contraindication use inhaled steroid COPD ( i.e . chronic bronchitis emphysema ) and/or relevant lung disease cause alternate impairment lung function Current smoking 10 packyears Previous smoke 10 packyears Use systemic steroid 4 week ( injectable depot steroid 6 week ) entry baseline period , 2 time Pregnancy Intention become pregnant course study Breast feeding Lack safe contraception</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Asthma</keyword>
	<keyword>Ciclesonide</keyword>
	<keyword>Fluticasone propionate</keyword>
</DOC>